Evidence map›Paper›PMID 36443308›Full record

ArticleNature communications2022

Secreted EMC10 is upregulated in human obesity and its neutralizing antibody prevents diet-induced obesity in mice.

Xuanchun Wang, Yanliang Li, Guifen Qiang, Kaihua Wang, Jiarong Dai, Maximilian McCann, Marcos D Munoz, Victoria Gil, Yifei Yu, Shengxian Li and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 3 countries.

Xuanchun Wang *Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China. wangxch@fudan.edu.cn.ORCID 0000-0003-2980-4363
Yanliang Li *Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Guifen Qiang *Department of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0001-9098-790X
Kaihua Wang *State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Jiarong DaiDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-2804-4019
Maximilian McCannDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0001-8661-430X
Marcos D MunozDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.
Victoria GilDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0002-2569-4163
Yifei YuDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Shengxian LiDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.
Zhihong YangResearch Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Shanshan XuDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA.
Jose Cordoba-ChaconDepartment of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0001-8787-2706
Dario F De JesusResearch Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-8826-9095
Bei SunNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Kuangyang ChenDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Yahao WangDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Xiaoxia LiuDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Qing MiaoDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Linuo ZhouDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Renming HuDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, China.
Qiang DingDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Rohit N KulkarniResearch Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-5029-6119
Daming GaoState Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, CAS Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0003-4374-1055
Matthias BlüherDepartment of Medicine, University of Leipzig, Leipzig, Germany.ORCID 0000-0003-0208-2065
Chong Wee LiewDepartment of Physiology & Biophysics, University of Illinois at Chicago, Chicago, IL, USA. cwliew@uic.edu.ORCID 0000-0001-9904-0958
Fudan University · CNUniversity of Illinois Chicago · USJoslin Diabetes Center · USChinese Academy of Sciences · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNLeipzig University · DEShanghai Jiao Tong University · CNTianjin Medical University · CN

Funding

Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2013 to 2026
$20.9M
Coordinating Unit for DiaCompU24DK115255 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2017 to 2020
$11.6M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
EMC10, a novel obesity-regulated circulating factor, regulates energy and metabolic homeostasisR01DK109015 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIEW, CHONG WEE · 2016 to 2020
$1.8M
Role of the transcriptional coregulator, TRIP Br2, in adipocyte metabolismR00DK090210 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIEW, CHONG WEE · 2012 to 2014
$724k
NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P60 DK020595NIDDK NIH HHS R00 DK090210NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK109015NIDDK NIH HHS U24 DK076169NIDDK NIH HHS U24 DK115255
6 · The paper itself

Abstract

Secreted isoform of endoplasmic reticulum membrane complex subunit 10 (scEMC10) is a poorly characterized secreted protein of largely unknown physiological function. Here we demonstrate that scEMC10 is upregulated in people with obesity and is positively associated with insulin resistance. Consistent with a causal role for scEMC10 in obesity, Emc10

Indexed as

Antibodies, NeutralizingInsulin ResistanceAnimalsBiological TransportDietHumansMembrane ProteinsMiceMice, ObeseObesityAntibodies, NeutralizingEMC10 protein, humanEmc10 protein, mouseMembrane Proteins

Identifiers

PMID36443308
PMCPMC9705309
OpenAlexW4310154798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.